The SIGSbyBEVs project was structured around three primary work packages (WPs), each addressing key components for the development and validation of RNAi-based plant disease management strategies using BEVs
WP1: Identification and Design of Effective dsRNA Molecules.
This WP focused on identifying target genes in the fungal pathogens Fusarium circinatum and Fusarium oxysporum f. sp. lycopersici for RNAi. Through bioinformatic analyses and experimental validation, 11 essential target genes were identified for each pathogen, grouped into three functional pathways related to vesicle trafficking, cell wall synthesis, and signal transduction. Chimeric dsRNA molecules targeting multiple genes were designed to enhance silencing efficiency and minimize functional redundancy.
WP2: BEV Production and dsRNA Encapsulation.
Two bacterial strains, Escherichia coli and Bacillus subtilis, were optimized for BEV production. A novel polyethylene glycol (PEG)-based protocol was developed for BEV purification without ultracentrifugation, yielding vesicles of appropriate purity, size, and charge for dsRNA encapsulation. Multiple encapsulation methods, including electroporation, were tested, achieving up to 90% encapsulation efficiency while maintaining dsRNA integrity and protecting it from nuclease degradation.
WP3: Efficacy Testing of BEV-dsRNA Formulations.
In vitro assays demonstrated that BEV-encapsulated dsRNA reduced fungal growth by up to 80%, with significant gene expression suppression confirmed by RT-qPCR. In planta experiments showed that BEV-encapsulated dsRNA delayed disease progression by approximately two weeks in Pinus radiata seedlings infected with Fusarium circinatum, outperforming naked dsRNA treatments. However, due to the limited lab-scale production of BEV-dsRNA complex, experiments with Fusarium oxysporum f. sp. lycopersici in tomato required adaptation to hydroponic systems, yielding variable but promising results.